Trials / Withdrawn
WithdrawnNCT02575820
Old Blood and Postoperative Complications
The Effects of Old Red Blood Cell Transfusion on Morbidity in Patients Undergoing Revision Total Hip Arthroplasty: Retrospective Study
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators sought to examine the effects of 'old' red blood cells on mortality and morbidity of patients who undergoing revision hip replacement arthroplasty. The investigators hypothesis is that patients have an increased risk of mortality and infection after 'old' red blood cells transfusions compared with those who received 'new' transfusions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Old red blood cells transfusion | Red blood cells (shelf life \> 14 days) transfusion during the operation (total hip replacement arthroplasty) |
| PROCEDURE | New red blood cells transfusion | Red blood cells (shelf life =\< 14 days) transfusion during the operation (total hip replacement arthroplasty) |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-10-15
- Last updated
- 2016-05-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02575820. Inclusion in this directory is not an endorsement.